中国科学院机构知识库网格
Chinese Academy of Sciences Institutional Repositories Grid
首页
机构
成果
学者
登录
注册
登陆
×
验证码:
换一张
忘记密码?
记住我
×
校外用户登录
CAS IR Grid
机构
上海药物研究所 [13]
高能物理研究所 [10]
近代物理研究所 [10]
昆明植物研究所 [6]
植物研究所 [6]
国家天文台 [5]
更多
采集方式
OAI收割 [100]
iSwitch采集 [11]
内容类型
期刊论文 [110]
会议论文 [1]
发表日期
2025 [1]
2024 [3]
2023 [4]
2022 [9]
2021 [4]
2020 [11]
更多
学科主题
Ecology [4]
Multidisci... [4]
Geography,... [2]
Biochemist... [1]
Plant Scie... [1]
天文和天体物理 [1]
更多
筛选
浏览/检索结果:
共111条,第1-10条
帮助
条数/页:
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
排序方式:
请选择
提交时间升序
提交时间降序
作者升序
作者降序
题名升序
题名降序
发表日期升序
发表日期降序
USP7 V517F mutation as a mechanism of inhibitor resistance
期刊论文
OAI收割
NATURE COMMUNICATIONS, 2025, 卷号: 16, 期号: 1, 页码: 14
作者:
Miao, Yu-Ling
;
Fan, Fengying
;
Cheng, Yong-Jun
;
Jia, Li
;
Song, Shan-Shan
  |  
收藏
  |  
浏览/下载:19/0
  |  
提交时间:2025/05/27
Multidisciplinary and multiscale nanoscience research roadmap based on large scientific facilities
期刊论文
OAI收割
SCIENCE CHINA-CHEMISTRY, 2024
作者:
Zeng, Yuan
;
Zhang, Shuhan
;
Guo, Yuecong
;
Cong, Yalin
;
Ding, Xu
  |  
收藏
  |  
浏览/下载:32/0
  |  
提交时间:2024/11/20
large scientific facilities
synchrotron radiation
FEL light sources
neutron sources
spectroscopic analysis methods
X-ray imaging techniques
structural information
chemical dynamics
Accessing 7,8-Dihydroquinoline-2,5-diones via Rh-Catalyzed Olefinic C-H Activation/[4+2] Cyclization
期刊论文
OAI收割
ORGANIC LETTERS, 2024, 页码: 5
作者:
Liu, Xueqing
;
Shi, Sijia
;
Ding, Wenqian
;
He, Zhiyue
;
Shen, Yu
  |  
收藏
  |  
浏览/下载:56/0
  |  
提交时间:2024/07/12
New constraints on Triton's atmosphere from the 6 October 2022 stellar occultation
期刊论文
OAI收割
ASTRONOMY & ASTROPHYSICS, 2024, 卷号: 684, 页码: L13
作者:
Yuan, Ye
;
Zhang, Chen
;
Li, Fan
;
Chen, Jian
;
Fu, Yanning
  |  
收藏
  |  
浏览/下载:25/0
  |  
提交时间:2024/07/09
techniques: photometric
occultations
planets and satellites: atmospheres
planets and satellites: physical evolution
planets and satellites: individual: Triton
Identification of [1,2,4]Triazolo[4,3-a]pyrazine PARP1 inhibitors with overcome acquired resistance activities
期刊论文
OAI收割
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2023, 卷号: 259, 页码: 19
作者:
Wang, Pingyuan
;
Zhu, Wen-Ting
;
Wang, Yajing
  |  
收藏
  |  
浏览/下载:84/0
  |  
提交时间:2023/10/17
PARP1 inhibitor
Synthetic lethality
Drug resistance
Anticancer
Structure -activity relationship
A Spectral-timing Study of the Inner Flow Geometry in MAXI J1535-571 with Insight-HXMT and NICER
期刊论文
OAI收割
ASTROPHYSICAL JOURNAL, 2023, 卷号: 953, 期号: 2, 页码: 12
作者:
Yu, Wei
;
Bu, Qing-Cui
;
Liu, He-Xin
;
Huang, Yue
;
Zhang, Liang
  |  
收藏
  |  
浏览/下载:51/0
  |  
提交时间:2023/11/14
Thioparib inhibits homologous recombination repair, activates the type I IFN response, and overcomes olaparib resistance
期刊论文
OAI收割
EMBO MOLECULAR MEDICINE, 2023, 页码: 24
作者:
Wang, Li-Min
;
Wang, Pingyuan
;
Chen, Xiao-Min
;
Yang, Hui
;
Song, Shan-Shan
  |  
收藏
  |  
浏览/下载:66/0
  |  
提交时间:2023/04/10
homologous recombination repair
olaparib-resistant
PARP inhibitor
PARP7
type I interferons
Phloroglucinol derivatives with α-glucosidase inhibitory activities from Syzygium fluviatile
期刊论文
OAI收割
JOURNAL OF ASIAN NATURAL PRODUCTS RESEARCH, 2023, 卷号: 25, 期号: 12, 页码: 1168-1174
作者:
Zhang,Ding-Li
;
Hu,Yi-Kao
;
Wang,Li
;
He,Yuan-Biao
;
Yang,Jing
  |  
收藏
  |  
浏览/下载:22/0
  |  
提交时间:2024/07/31
Syzygium fluviatile
phloroglucinol
alpha-glucosidase
Global Gridded Ionospheric Electron Density Derivation During 2006-2016 by Assimilating COSMIC TEC and Its Validation
期刊论文
OAI收割
JOURNAL OF GEOPHYSICAL RESEARCH-SPACE PHYSICS, 2022, 卷号: 127, 期号: 12, 页码: 17
作者:
He, Jianhui
;
Yue, Xinan
;
Astafyeva, Elvira
;
Le, Huijun
;
Ren, Zhipeng
  |  
收藏
  |  
浏览/下载:52/0
  |  
提交时间:2023/03/29
Design, synthesis and pharmacological evaluation of new PARP1 inhibitors by merging pharmacophores of olaparib and the natural product alantolactone
期刊论文
OAI收割
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2022, 卷号: 240, 页码: 114574
作者:
Kayumov, Muzaffar
;
Jia, Li
;
Pardaev, Azizbek
;
Song, Shan-Shan
;
Mirzaakhmedov, Sharafitdin
  |  
收藏
  |  
浏览/下载:44/0
  |  
提交时间:2024/03/21
PARP1
Olaparib
Alantolactone
Syntheticlethality
BRCA1/2mutant